APO RESEARCH · REPORT
L-Valine
L-Valine is one of 8 kinds of essential amino acid. It works with other two kinds of high concentration amino acid (isoleucine and leucine) to improve body normal growth, repair tissue, regulate blood glucose and provide with required energy.
Product & engineering
Understand the product.
L-Valine is one of 8 kinds of essential amino acid. It works with other two kinds of high concentration amino acid (isoleucine and leucine) to improve body normal growth, repair tissue, regulate blood glucose and provide with required energy.
Selected research
Industry Research
L-Valine Industry Research Report 2026
Market perspective
L-Valine is one of 8 kinds of essential amino acid. It works with other two kinds of high concentration amino acid (isoleucine and leucine) to improve body normal growth, repair tissue, regulate blood glucose and provide with required energy.
Ajinomoto, Kyowa Hakko, Evonik, CJ and Fufeng Group are the key suppliers in the global L-valine market. Top five take up about 73% of the global production market. And the production of Ajinomoto occupied about 27%.
The China market took up about 38% the global market, followed by Europe (23%).
Read the full market overview
Report Scope
This report quantifies the global L-Valine market in revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to L-Valine.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
L-Valine Market by Company
Ajinomoto
Kyowa Hakko
Evonik
CJ
Fufeng Group
Maidan Biology
Meihua Group
Yichang Sanxia Pharmaceutical
Star Lake Bioscience
Tianjin Tianan
Wellman Bioscience
Jinghai Amino Acid
Bafeng Pharmaceutical
Jiahe Biotech
Luzhou Group
Jirong Pharmaceutical
L-Valine Segment by Type
Pharmaceutical Grade
Food Grade
Feed Grade
Other
L-Valine Segment by Application
Pharmaceutical Industry
Food Industry
Feed Industry
Other
L-Valine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global L-Valine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of L-Valine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of L-Valine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of L-Valine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of L-Valine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of L-Valine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pharmaceutical Grade
- Food Grade
- Feed Grade
- Other
Applications
- Pharmaceutical Industry
- Food Industry
- Feed Industry
- Other
Companies covered
- Ajinomoto
- Kyowa Hakko
- Evonik
- CJ
- Fufeng Group
- Maidan Biology
- Meihua Group
- Yichang Sanxia Pharmaceutical
- Star Lake Bioscience
- Tianjin Tianan
- Wellman Bioscience
- Jinghai Amino Acid
- Bafeng Pharmaceutical
- Jiahe Biotech
- Luzhou Group
- Jirong Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 L-Valine by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Pharmaceutical Grade
- 2.2.3 Food Grade
- 2.2.4 Feed Grade
- 2.2.5 Other
- 2.3 L-Valine by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pharmaceutical Industry
- 2.3.3 Food Industry
- 2.3.4 Feed Industry
- 2.3.5 Other
- 2.4 Global Market Growth Prospects
- 2.4.1 Global L-Valine Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global L-Valine Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global L-Valine Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global L-Valine Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global L-Valine Production by Manufacturers (2021-2026)
- 3.2 Global L-Valine Production Value by Manufacturers (2021-2026)
- 3.3 Global L-Valine Average Price by Manufacturers (2021-2026)
- 3.4 Global L-Valine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global L-Valine Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global L-Valine Manufacturers, Product Type & Application
- 3.7 Global L-Valine Manufacturers Established Date
- 3.8 Global L-Valine Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Ajinomoto
- 4.1.1 Ajinomoto L-Valine Company Information
- 4.1.2 Ajinomoto L-Valine Business Overview
- 4.1.3 Ajinomoto L-Valine Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Ajinomoto Product Portfolio
- 4.1.5 Ajinomoto Recent Developments
- 4.2 Kyowa Hakko
- 4.2.1 Kyowa Hakko L-Valine Company Information
- 4.2.2 Kyowa Hakko L-Valine Business Overview
- 4.2.3 Kyowa Hakko L-Valine Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Kyowa Hakko Product Portfolio
- 4.2.5 Kyowa Hakko Recent Developments
- 4.3 Evonik
- 4.3.1 Evonik L-Valine Company Information
- 4.3.2 Evonik L-Valine Business Overview
- 4.3.3 Evonik L-Valine Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Evonik Product Portfolio
- 4.3.5 Evonik Recent Developments
- 4.4 CJ
- 4.4.1 CJ L-Valine Company Information
- 4.4.2 CJ L-Valine Business Overview
- 4.4.3 CJ L-Valine Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 CJ Product Portfolio
- 4.4.5 CJ Recent Developments
- 4.5 Fufeng Group
- 4.5.1 Fufeng Group L-Valine Company Information
- 4.5.2 Fufeng Group L-Valine Business Overview
- 4.5.3 Fufeng Group L-Valine Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Fufeng Group Product Portfolio
- 4.5.5 Fufeng Group Recent Developments
- 4.6 Maidan Biology
- 4.6.1 Maidan Biology L-Valine Company Information
- 4.6.2 Maidan Biology L-Valine Business Overview
- 4.6.3 Maidan Biology L-Valine Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Maidan Biology Product Portfolio
- 4.6.5 Maidan Biology Recent Developments
- 4.7 Meihua Group
- 4.7.1 Meihua Group L-Valine Company Information
- 4.7.2 Meihua Group L-Valine Business Overview
- 4.7.3 Meihua Group L-Valine Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Meihua Group Product Portfolio
- 4.7.5 Meihua Group Recent Developments
- 4.8 Yichang Sanxia Pharmaceutical
- 4.8.1 Yichang Sanxia Pharmaceutical L-Valine Company Information
- 4.8.2 Yichang Sanxia Pharmaceutical L-Valine Business Overview
- 4.8.3 Yichang Sanxia Pharmaceutical L-Valine Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Yichang Sanxia Pharmaceutical Product Portfolio
- 4.8.5 Yichang Sanxia Pharmaceutical Recent Developments
- 4.9 Star Lake Bioscience
- 4.9.1 Star Lake Bioscience L-Valine Company Information
- 4.9.2 Star Lake Bioscience L-Valine Business Overview
- 4.9.3 Star Lake Bioscience L-Valine Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Star Lake Bioscience Product Portfolio
- 4.9.5 Star Lake Bioscience Recent Developments
- 4.10 Tianjin Tianan
- 4.10.1 Tianjin Tianan L-Valine Company Information
- 4.10.2 Tianjin Tianan L-Valine Business Overview
- 4.10.3 Tianjin Tianan L-Valine Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Tianjin Tianan Product Portfolio
- 4.10.5 Tianjin Tianan Recent Developments
- 4.11 Wellman Bioscience
- 4.11.1 Wellman Bioscience L-Valine Company Information
- 4.11.2 Wellman Bioscience L-Valine Business Overview
- 4.11.3 Wellman Bioscience L-Valine Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Wellman Bioscience Product Portfolio
- 4.11.5 Wellman Bioscience Recent Developments
- 4.12 Jinghai Amino Acid
- 4.12.1 Jinghai Amino Acid L-Valine Company Information
- 4.12.2 Jinghai Amino Acid L-Valine Business Overview
- 4.12.3 Jinghai Amino Acid L-Valine Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Jinghai Amino Acid Product Portfolio
- 4.12.5 Jinghai Amino Acid Recent Developments
- 4.13 Bafeng Pharmaceutical
- 4.13.1 Bafeng Pharmaceutical L-Valine Company Information
- 4.13.2 Bafeng Pharmaceutical L-Valine Business Overview
- 4.13.3 Bafeng Pharmaceutical L-Valine Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 Bafeng Pharmaceutical Product Portfolio
- 4.13.5 Bafeng Pharmaceutical Recent Developments
- 4.14 Jiahe Biotech
- 4.14.1 Jiahe Biotech L-Valine Company Information
- 4.14.2 Jiahe Biotech L-Valine Business Overview
- 4.14.3 Jiahe Biotech L-Valine Production Capacity, Value and Gross Margin (2021-2026)
- 4.14.4 Jiahe Biotech Product Portfolio
- 4.14.5 Jiahe Biotech Recent Developments
- 4.15 Luzhou Group
- 4.15.1 Luzhou Group L-Valine Company Information
- 4.15.2 Luzhou Group L-Valine Business Overview
- 4.15.3 Luzhou Group L-Valine Production Capacity, Value and Gross Margin (2021-2026)
- 4.15.4 Luzhou Group Product Portfolio
- 4.15.5 Luzhou Group Recent Developments
- 4.16 Jirong Pharmaceutical
- 4.16.1 Jirong Pharmaceutical L-Valine Company Information
- 4.16.2 Jirong Pharmaceutical L-Valine Business Overview
- 4.16.3 Jirong Pharmaceutical L-Valine Production Capacity, Value and Gross Margin (2021-2026)
- 4.16.4 Jirong Pharmaceutical Product Portfolio
- 4.16.5 Jirong Pharmaceutical Recent Developments
5 Global L-Valine Production by Region
- 5.1 Global L-Valine Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global L-Valine Production by Region: 2021-2032
- 5.2.1 Global L-Valine Production by Region: 2021-2026
- 5.2.2 Global L-Valine Production Forecast by Region (2027-2032)
- 5.3 Global L-Valine Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global L-Valine Production Value by Region: 2021-2032
- 5.4.1 Global L-Valine Production Value by Region: 2021-2026
- 5.4.2 Global L-Valine Production Value Forecast by Region (2027-2032)
- 5.5 Global L-Valine Market Price Analysis by Region (2021-2026)
- 5.6 Global L-Valine Production and Value, YOY Growth
- 5.6.1 North America L-Valine Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe L-Valine Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China L-Valine Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan L-Valine Production Value Estimates and Forecasts (2021-2032)
6 Global L-Valine Consumption by Region
- 6.1 Global L-Valine Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global L-Valine Consumption by Region (2021-2032)
- 6.2.1 Global L-Valine Consumption by Region: 2021-2026
- 6.2.2 Global L-Valine Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America L-Valine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America L-Valine Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe L-Valine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe L-Valine Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific L-Valine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific L-Valine Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa L-Valine Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa L-Valine Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global L-Valine Production by Type (2021-2032)
- 7.1.1 Global L-Valine Production by Type (2021-2032) & (MT)
- 7.1.2 Global L-Valine Production Market Share by Type (2021-2032)
- 7.2 Global L-Valine Production Value by Type (2021-2032)
- 7.2.1 Global L-Valine Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global L-Valine Production Value Market Share by Type (2021-2032)
- 7.3 Global L-Valine Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global L-Valine Production by Application (2021-2032)
- 8.1.1 Global L-Valine Production by Application (2021-2032) & (MT)
- 8.1.2 Global L-Valine Production Market Share by Application (2021-2032)
- 8.2 Global L-Valine Production Value by Application (2021-2032)
- 8.2.1 Global L-Valine Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global L-Valine Production Value Market Share by Application (2021-2032)
- 8.3 Global L-Valine Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 L-Valine Value Chain Analysis
- 9.1.1 L-Valine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 L-Valine Production Mode & Process
- 9.2 L-Valine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 L-Valine Distributors
- 9.2.3 L-Valine Customers
10 Global L-Valine Analyzing Market Dynamics
- 10.1 L-Valine Industry Trends
- 10.2 L-Valine Industry Drivers
- 10.3 L-Valine Industry Opportunities and Challenges
- 10.4 L-Valine Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst